Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07428044Phase 2Withdrawn
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
Non-Small Cell Lung CancerNon-small Cell Lung Cancer Stage IINon-Small Cell Lung Cancer Stage IIIA+1 more
PrincipalinvestigatorStart date: 2026-02-13

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ciro Gallo, M.D., Ph.D.

University of Campania Luigi Vanvitelli

Related
8 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score8%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score8%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung

Worked with same sponsors:

AstraZeneca
Similarity Score8%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score8%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Related
19 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score8%

Zhengfei Zhu, MD

Fudan University

Related
8 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score8%

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung

Worked with same sponsors:

AstraZeneca
Similarity Score8%

Francesco Perrone, M.D., Ph.D

National Cancer Institute Naples, Italy; Director Clinical Trials Unit

Related
9 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer Stage IIIB
Similarity Score8%

Urielle Desalbres

Assistance Publique Hôpitaux de Marseille

Related
71 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score8%

Francesco Perrone, M.D., Ph.D.

National Cancer Institute, Naples

Related
13 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07428044Phase 2PrincipalInvestigator

A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

Non-Small Cell Lung CancerNon-small Cell Lung Cancer Stage IINon-Small Cell Lung Cancer Stage IIIA+1 more
Withdrawn

All 1 trials loaded